Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00609453 · ClinicalTrials.gov registry record · NA

Brain Imaging of Psychotherapy for Depression

A NA study of Major Depressive Disorder, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT00609453: Completed NA study of Major Depressive Disorder, sponsored by University of North Carolina, Chapel Hill.

NCT00609453 is a NA study of Major Depressive Disorder that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 27 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00609453, a NA study of Major Depressive Disorder, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The goal of the proposed research is to examine the neural correlates of depressive symptom reduction in individuals with major depressive disorder using functional magnetic resonance imaging (fMRI), and to compare results to those obtained from a nondepressed control group.

Conditions Studied

Interventions

  • BEHAVIORAL Brief Behavioral Activation Treatment for Depression

Study Locations (1)

North Carolina

  • Duke-UNC Brain Imaging and Analysis Center - Durham

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2006-10
Est. Completion 2008-01
Phase NA

What the finished NCT00609453 record still lists

NCT00609453 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Brief Behavioral Activation Treatment for Depression is the first listed.

NCT00609453 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT00609453 about?

NCT00609453 is a clinical study titled "Brain Imaging of Psychotherapy for Depression". The goal of the proposed research is to examine the neural correlates of depressive symptom reduction in individuals with major depressive disorder using functional magnetic resonance imaging (fMRI), and to compare results to those obtained from a nondepressed control group.

What is the current status of trial NCT00609453?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2006-10. Estimated completion is 2008-01.

What conditions does trial NCT00609453 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT00609453?

The interventions under investigation include: Brief Behavioral Activation Treatment for Depression (BEHAVIORAL).

Who is sponsoring clinical trial NCT00609453?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00609453 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00609453's enrollment target sits among peer trials

27 230th of 282 higher than 53 of 282 other Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00609453, the US trial registry maintained by the National Library of Medicine. NCT00609453 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.